Financial Enhancement Group’s Colgate-Palmolive CL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-600
Closed -$42K 151
2022
Q3
$42K Hold
600
0.01% 145
2022
Q2
$48K Hold
600
0.01% 137
2022
Q1
$45K Hold
600
0.01% 140
2021
Q4
$51K Hold
600
0.01% 137
2021
Q3
$45K Hold
600
0.01% 138
2021
Q2
$49K Sell
600
-1,484
-71% -$121K 0.01% 126
2021
Q1
$164K Buy
2,084
+8
+0.4% +$627 0.03% 97
2020
Q4
$178K Buy
2,076
+8
+0.4% +$662 0.04% 98
2020
Q3
$160K Buy
2,068
+8
+0.4% +$610 0.04% 94
2020
Q2
$151K Buy
2,060
+9
+0.4% +$639 0.04% 98
2020
Q1
$136K Buy
2,051
+8
+0.4% +$564 0.04% 100
2019
Q4
$141K Buy
2,043
+9
+0.4% +$614 0.04% 89
2019
Q3
$149K Buy
2,034
+9
+0.4% +$653 0.04% 86
2019
Q2
$145K Buy
2,025
+8
+0.4% +$568 0.04% 95
2019
Q1
$138K Buy
2,017
+9
+0.4% +$581 0.04% 97
2018
Q4
$134K Hold
2,008
0.04% 97
2018
Q3
$134K Hold
2,008
0.04% 97
2018
Q2
$130K Hold
2,008
0.04% 92
2018
Q1
$144K Buy
+2,008
New +$145K 0.05% 93

Other funds holding CL

Financial Enhancement Group's CL Position: Q4 2022 in Review

Financial Enhancement Group sold out of Colgate-Palmolive (CL) in Q4 2022, closing a stake of 600 shares — an estimated $42K sold.

Financial Enhancement Group first reported a position in CL in Q1 2018 and held it in 19 quarters. The position peaked at $178K in Q4 2020. 1,698 funds tracked by Wall St. Rank hold CL as of Q4 2022.

  • Financial Enhancement Group reported no remaining Colgate-Palmolive position as of Q4 2022 after selling out during the quarter.
  • Financial Enhancement Group sold 600 Colgate-Palmolive shares in Q4 2022, an estimated $42K.
  • Financial Enhancement Group first reported a position in Colgate-Palmolive in Q1 2018 and held it in 19 quarters.
  • Financial Enhancement Group's Colgate-Palmolive position peaked at $178K in Q4 2020.
  • 1,698 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q4 2022.

Based on Financial Enhancement Group's 13F filing for Q4 2022, filed 9 Feb 2023.